On Invalid Date, Atyr Pharma (NASDAQ: LIFE) reported Q4 2023 earnings per share (EPS) of -$0.25, up 3.85% year over year. Total Atyr Pharma earnings for the quarter were -$14.76 million. In the same quarter last year, Atyr Pharma's earnings per share (EPS) was -$0.26.
As of Q2 2024, Atyr Pharma's earnings has grown year over year. Atyr Pharma's earnings in the past year totalled -$50.39 million.
What is LIFE's earnings date?
Atyr Pharma's earnings date is Invalid Date. Add LIFE to your watchlist to be reminded of LIFE's next earnings announcement.
What was LIFE's revenue last quarter?
On Invalid Date, Atyr Pharma (NASDAQ: LIFE) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Atyr Pharma's revenue was $10.39 million.
What was LIFE's revenue growth in the past year?
As of Q2 2024, Atyr Pharma's revenue has grown -96.6% year over year. This is 245.9 percentage points lower than the US Biotechnology industry revenue growth rate of 149.3%. Atyr Pharma's revenue in the past year totalled $353.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.